Congenital Disorders of Glycosylation: Clinical Trials

9 trials for Congenital Disorders of Glycosylation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 recruiting, 1 unknown. 2 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 11Recruiting 1

Follow Congenital Disorders of Glycosylation: new trials by email Literature Review of Congenital Disorders of Glycosylation trials Research Report on Congenital Disorders of Glycosylation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessing the Safety and Tolerability of NMN in DHDDS-CDG
Nicotinamide Mononucleotide (NMN) Nucleosidase - DHDDS-Congenital Disorder of Glycosylation, DHDDS-CDG
Phase 1RecruitingEva Morava-Kozicz82026-05-082026-06-22
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
Congenital Disorders of Glycosylation
RecruitingIcahn School of Medicine at Mount Sinai5002019-10-082026-07-21
Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism
Congenital Disorders of Glycosylation
CompletedMayo Clinic2402019-10-082025-10-03
Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation
Congenital Disorder of Glycosylation
CompletedMayo Clinic202018-12-062025-10-01
Role of the Endothelium in Stroke-like Episode Among CDG Patients
Peripheral blood puncture - Congenital Disorders of Glycosylation
Not applicableCompletedAssistance Publique - Hôpitaux de Paris62017-11-232026-04-03
"Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"
none intervention - Congenital Heart Diseases, Conotruncal Defects
UnknownHospital Universitari Vall d'Hebron Research Institute3002015-07-012017-03-27
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation
D-Galactose - Congenital Disorders of Glycosylation
Not applicableCompletedTulane University82014-07-012021-01-08
Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Congenital Disorders of Glycosylation
RecruitingNational Human Genome Research Institute (NHGRI)2002014-03-072026-10-26
Study of Hemostasis in Patients With Congenital Disorder of Glycosylation
Coagulation assay, Clinical data collection - Congenital Disorders of Glycosylation
CompletedAssistance Publique - Hôpitaux de Paris572014-01-012026-03-05

Narrower conditions

Thrombosis (2)  ·  Antithrombin III Deficiency (1)  ·  Glucose Metabolism Disorders (1)  ·  Heart Defects, Congenital (1)  ·  Hemorrhage (1)  ·  Hypoglycemia (1)  ·  Hypothyroidism (1)  ·  Intellectual Disability (1)  ·  Muscle Hypotonia (1)

Broader conditions

Carbohydrate Metabolism, Inborn Errors (9)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Genetic Diseases, Inborn (9)  ·  Metabolic Diseases (9)  ·  Metabolism, Inborn Errors (9)  ·  Nutritional and Metabolic Diseases (9)  ·  Cardiovascular Diseases (3)  ·  Embolism and Thrombosis (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Abnormalities (1)  ·  Congenital Abnormalities (1)

Interventions

Bleeding Time (1)  ·  Galactose (1)  ·  NMN nucleosidase (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  Mayo Clinic (2)  ·  Eva Morava-Kozicz (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  National Human Genome Research Institute (NHGRI) (1)  ·  Tulane University (1)

Countries

United States (6)  ·  France (2)  ·  Spain (1)

Top investigators

David Deyle, MD (2)  ·  Eva Morava-Kozicz, MD, PhD (2)  ·  Delphine Borgel, MD, PhD (1)  ·  Delphine Borgel, PharmaD, PhD (1)  ·  Eva Morava, MD, PhD (1)  ·  Lynne A Wolfe, C.R.N.P. (1)  ·  Pascale De Lonlay, MD, PhD (1)

Results publications

PMID 31271700, PMID 33743737

NIH funding

U54NS115198 (2)